• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

Revive Therapeutics inks R&D deal with Sanyal for liver disease treatments

October 2, 2017 By Fink Densford

Revive Therapeutics

Revive Therapeutics (OTC:RVVTF) said today it inked a collaborative research deal with Sanyal Biotechnology looking to explore the use of cannabinoids as potential treatments for liver diseases. The collaborative deal will initially focus on the use of cannabidiol on a novel autoimmune hepatitis model, using the Diamond model which was designed and developed by Sanyal Biotechnologyspecifically […]

Filed Under: Featured, Research & Development Tagged With: revivetherapeutics, sanyalbiotechnology

Seattle Genetics wins FDA Breakthrough Therapy Designation for Hodgkin lymphoma treatment

October 2, 2017 By Fink Densford

Seattle Genetics

Seattle Genetics (NSDQ:SGEN) said today that the FDA granted Breakthrough Therapy Designation to its antibody-drug conjugate Adcetris in combination with chemotherapy for treating patients with advanced classical Hodgkin lymphoma. The approval was based on positive top line results from the company’s phase 3 Echelon-1 clinical trial, which were announced in June. The Bothell, Wash.-based company said […]

Filed Under: Featured, Food & Drug Administration (FDA), Oncology, Research & Development Tagged With: Seattle Genetics

J&J’s Janssen wins $45m BARDA contract for Ebola vaccine dev

October 2, 2017 By Fink Densford

Janssen

Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical subsidiary Janssen Vaccines & Prevention B.V received a $44.7 million award and collaborative partnership from the US Biomedical Advanced Research and Development Authority to support its development of an investigational Ebola vaccine regimen. The deal comes with an option for BARDA to provide additional funding over 5 […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Research & Development Tagged With: Janssen Pharmaceuticals, johnsonandjohnson

Medtech stories we missed this week: Sept. 22, 2017

September 22, 2017 By Danielle Kirsh

missed-medtech-0922

From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Hospital Care, mHealth (Mobile Health), Regulatory/Compliance, Research & Development Tagged With: Bioventus LLC, Contego Medical, Covalon Technologies, Getinge, Guerbet, IBA, ManaMed, medovex, medtech

Nestle plans to slash headcount at Galderma R&D center

September 21, 2017 By Sarah Faulkner

Galderma

(Reuters) – Nestle plans to cut up to 450 jobs at a Galderma research and development center in southern France, the Swiss company said on Thursday, as it seeks to make the underperforming skin health business more efficient. Galderma, which Nestle took over from its joint venture partner L’Oreal in 2014, will cut as many as […]

Filed Under: Featured, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Galderma

Microneedle skin patch delivers fat-burning drug in mouse trial

September 15, 2017 By Sarah Faulkner

Researchers have created a drug-filled microneedle skin patch that helps convert energy-storing fat, or white fat, into energy-burning fat, or brown fat – all the while boosting the body’s metabolism. The team of researchers at Columbia University Medical Center and the University of North Carolina reported that their patch could one day be used to burn […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Preclinical Trials, Research & Development Tagged With: columbiauniversity, University of North Carolina

Drug-carrying particle contains multiple doses of vaccine – in one injection

September 15, 2017 By Sarah Faulkner

vaccine tech from Langer lab

Researchers from Massachusetts Institute of Technology have invented a method to generate drug-ferrying particles that can deliver multiple doses of a vaccine over an extended length of time with just one injection. The particles, made from a biocompatible, FDA-approved polymer, look like tiny coffee cups that can be filled with a drug and sealed. The polymer […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

Study: 30% of T2D patients don’t start insulin therapy when recommended

September 14, 2017 By Sarah Faulkner

insulin

Research from Brigham & Women’s Hospital, supported by Sanofi (NYSE:SNY), found that 30% of people with Type II diabetes don’t begin insulin therapy when it’s first recommended to them. On average, these patients are delaying treatment by two years, the researchers reported. The team’s work was published in the journal of Diabetic Medicine. “Unfortunately this isn’t uncommon, […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: Brigham & Women's Hospital, Sanofi-Aventis

KemPharm tackles pediatric ADHD using ligand-activated drug

September 14, 2017 By Sarah Faulkner

kempharm

Travis Mickle’s work developing better drugs for attention deficit hyperactivity disorder is deeply personal – he has ADHD and so do his children. After receiving his PhD in organic chemistry from the University of Iowa, Mickle went on to work at New River Pharmaceuticals, where he developed the leading treatment for ADHD, Vyvanse. Now he […]

Filed Under: Clinical Trials, Featured, Neurological, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: kempharm

Study suggests Type II diabetes is being misdiagnosed in African-Americans

September 12, 2017 By Sarah Faulkner

diabetes

A test used to diagnose Type II diabetes and monitor blood sugar levels could be leaving hundreds of thousands of diabetic African Americans in the U.S. undiagnosed, according to a study published today in PLOS Medicine. The test uses 60 genetic variants, according to a team of scientists, and one of those genetic variants is found […]

Filed Under: Diabetes, Diagnostics, Featured, Research & Development Tagged With: Massachusetts General Hospital, wellcometrustsangerinstitute

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS